Clinical Trials Logo

Clinical Trial Summary

Serenno Medical Automatic Urine Output measuring device is intended to measure volumetric flow rate (total volume and rate) of urine produced per minute over long periods by a patient with a urinary catheter as well as high resolution IAP via bladder pressure (IBP). The device comprises a control unit located near the bed, and a disposable unit connected between the catheter and the urine collection tube/bag. The disposable unit is connected to the control unit with a tube. Frequent and accurate Intra-Abdominal Pressure measurements facilitate management of critical care patients, yet this parameter is normally measured manually, intermittently, and inaccurately. Automating IAP measurement will increase responsiveness, reduce workload, and potentially improve outcomes. The investigators goal is to validate the accuracy urinary catheter estimates of IAP compared to the gold standard during the application of a wide range of pressures controlled by a validated closed-loop insufflation reference. Primary Objective: The study objective is to evaluate the accuracy of the Serenno Medical IAP measurements in patients with indwelling urinary catheters vs. the gold standard - the Foley Manometer


Clinical Trial Description

The system which is the subject of the current study comprises two connected parts, the controller and the disposable.The disposable is a special pressure sensing fluid pump connected serially between the catheter and urine bag. The pump is operated by controlled air pressures sent via three tubes from the controller. The pump operates in strokes, with each stroke passing exactly 1ml of fluid from the input port which is connected to the catheter in the patients' bladder, to the output port, which is connected via a long tube to the urine collection container (bag or other). Since each stroke of the pump is known and constant, and the monitor is counting and timing the strokes both current urine production rate, flow rate and cumulative urine volume over any period can be measured. The pump is also unique in that its design allows the controller to measure the fluid pressure at both the input port, as well as in the output port allowing automatic high resolution Intra-Abdominal pressure monitoring in parallel and without interrupting the Urine Output monitoring. Ongoing pressure monitoring and supporting algorithm remove the need to manually fill and empty the bladder and avoid interrupting urine output monitoring. The method also delivers multiple per-hour IAP measurements and is able to show trends to correlate to patient angle and condition. Urine pumping eliminates all problems associated with existing systems and methods for measuring urine output. The volume measurement is accurate since it is measured in a "digital" format, by calculating of number of fixed bolus units transferred. Dependent loop and tube related accumulation are avoided since the pump passes a fixed volume of urine, no matter how it is distributed in the drain tube. Similarly, urine composition, temperature, production rate, specific weight are irrelevant to the pumping accuracy, as well as patient/bed motions and vibrations. The controller operates the pump in a cyclic fashion. First, it measures the urine pressure inside the patients' bladder, as it is expressed as the pressure in the pump input port. A positive pressure of a few mmHg indicates that there is a minimal volume of urine in the bladder (and also indicate IAP). The controller then runs the pump for a single cycle, removing 1cc of urine from the bladder and repeating the pressure measurement and pump operation until the pressure at the input port drops back to zero - indicating an empty bladder, then stops. This process repeats for the duration of use. UO is calculated by the number of cycles and time of each divided by the relevant timeframe, normally cc/h.Providing a continuous fully automated and accurate method to measure IAP could be important in several clinical setups. Current reference methods for IAP measurement are intermittent and cumbersome. They are affected by body position, zero reference, and highly user dependent. Study design allows a large range of pressure levels assessed simultaneously between the study device and the gold standard. The study population is a good representation of the target population, being sedated in the supine position. Subjects will be recruited in the pre-operative period by the study staff. b. Study Duration (per subject and total): 33 patients (3 pilot patients) Durations from study device connection to removal during the OR procedure. Estimated 15 minutes. Total study duration is estimated as 12 months from its initiation. c. Study procedure: Screening Subjects will be screened according to eligibility criteria. The investigator will explain to the patient the nature of the study, its purpose, the procedures involved, the expected duration, the potential risks and benefits involved and any discomfort it may entail. The patients will be informed that participation in the study is voluntary, that the participants may withdraw from the study at any time and that withdrawal of consent will not affect his/her subsequent medical treatment (if any) or relationship with the treating physician. System set up, initiate data collection and follow up. A sealed envelope containing a set of 5 computer-generated random pressure insufflation targets will be opened. This will be used for stage 9. A new and sterile study device disposable pump will be used for each patient (study device). A new and sterile IAP Foley Manometer will be used for each patient. The Foley Manometer will be positioned so it is visible, stationary and it's zero point is at the same level as required in the device installation requirements at the level of the bladder. The study device Controller unit will be cleaned per OR procedures between uses (study device). If catheter is installed in the OR (as part of the OR requirements) it should not be drained to a bag and immediately connected to the Foley Manometer The investigator or study staff in the OR will connect the study device and IAP Foley Manometer to the patient urine line, noting the date and time. If needed for the IAP Foley Manometer reading and/or study device a fluid bolus of 25cc will be introduced and recorded. If needed, the battery of the device will be replaced as needed. Data storage card from the device will be backed up between uses. An investigator or study staff will perform a series of intermittent measurements using the Foley Manometer (manual IAP measurement) while the surgeon is changing the insufflation pressures to the preselected random targets, all between 8-25 mmHg. Each level will be maintained for a duration of 30 seconds. The study device will measure and save ongoing IAP during the process, measurements gathered by the study device will not be visible once measurements have started and can only be retrieved from the device memory during analysis. Urine Output functions will be turned off. After the set of measurements, the study device disposable unit and the manometer unit will be disconnectedNote: Disconnection of the patient from the study device control unit is considered as study termination. The surgical procedure will resume as normal. Study termination: system removal and documentation 1. The investigator in the OR will disconnect the study device and IAP Foley Manometer from the patient urine line. 2. The disconnected equipment will be sealed in a bio-hazard bag marked with the subject study number and returned to Serenno as soon as possible. After inspection it will be destroyed at the responsibility of Serenno. 3. The SD card carrying the patients' data will be removed from the controller, marked with the subject study number,. A new, blank SD card will be inserted in the controller in preparation for the next patient. 4. The controller can be used with the next patient after cleaning and disinfection per the OR normal operating procedures and IFU (instruction for use). 5. Patients' CRF will include information covering the study period will be extracted from the patient's medical files. The data included in the CRF shall include, at a minimum: i. Hospital records,, weight, BMI, ASA score or equivalent at admission. ii. The set of Foley Manometer IAP measurements and the set of insufflation levels and their timing preformed during the procedure (corresponding to the random values from the envelope). iii. Record of any unusual events during the study period, made by the OR staff iv. Record of any unusual events during the study period, made by a technical representative. v. Control unit and disposable units serial numbers used per session ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05121454
Study type Observational
Source Tel-Aviv Sourasky Medical Center
Contact Barak Cohen, MD
Phone +972527360368
Email [email protected]
Status Not yet recruiting
Phase
Start date November 15, 2021
Completion date October 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT01114971 - Labetalol and Esmolol: Vital Signs and Post Operative Pain Management Phase 4
Not yet recruiting NCT04999696 - Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical Cancer N/A
Completed NCT01084200 - Comparison of Sevoflurane, Propofol, and Sevoflurane Plus Propofol for Maintenance of Anaesthesia Phase 4
Not yet recruiting NCT00731107 - XCEL Bladeless Trocar Versus Veress Needle: A Randomised Controlled Trial Comparing These Two Entry Techniques in Gynaecological Laparoscopic Surgery. N/A
Recruiting NCT05005117 - Laparoscopic Approach for Emergency Colon Resection N/A
Not yet recruiting NCT04751812 - Venous Cannulation Pain to Guide Choice of Anesthetic Method N/A
Terminated NCT03684304 - The Effect of Abdominal Binder Use on Postoperative Pain and Mobility in Patients Undergoing Pelvic Surgery N/A
Completed NCT04146090 - Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy N/A
Terminated NCT01436032 - Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery Phase 3
Active, not recruiting NCT05109130 - Change of Circulating Tumor Cells Quantity in the Central Vein During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer.
Not yet recruiting NCT04392635 - Device to Assist With Abdominal Access During Laparoscopic Surgery N/A
Completed NCT04642118 - Low-pressure Pulmonary Recruitment Maneuver to Decrease Post-laparoscopic Shoulder Pain in Gynecologic Surgery N/A
Not yet recruiting NCT05092425 - Analysis of Risk Factors for Children With Heterochronous Indirect Hernia
Recruiting NCT03318185 - Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal Carcinoma N/A
Completed NCT03506555 - Laparoscopic Access in General Surgery: the Closed (Veress Needle) Technique Versus the Open (Hasson) Technique N/A
Not yet recruiting NCT02769325 - Atropine in Laparoscopic Gynaecological Surgery Phase 4
Completed NCT00944086 - Oxygen Concentration Should be Kept at the Lowest Possible Level During Recruitment N/A
Recruiting NCT04144933 - Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery Phase 3
Recruiting NCT04109339 - Effects of Oxytocin on Hemodynamics in Patients Undergoing Laparoscopic Myomectomy N/A
Completed NCT01552148 - Transversus Abdominis Plane Block for Laparoscopic Hysterectomy Phase 4